This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biocon Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Ravi Shankar Maurya
Introduction
Ravi Shankar Maurya is a notable inventor based in Gorakhpur, India. He has made significant contributions to the field of biotechnology, particularly in the detection of antibodies related to insulin. His work has implications for diabetes management and treatment.
Latest Patents
Ravi Shankar Maurya holds a patent for a method for detecting neutralizing antibodies against recombinant human insulin in human serum. This invention provides an in vitro method for detecting the presence of these antibodies, which is crucial for understanding patient responses to insulin therapy. Additionally, it includes a kit designed for the detection of recombinant human insulin neutralizing antibodies.
Career Highlights
Maurya is currently associated with Biocon Limited, a leading biopharmaceutical company. His role at Biocon Limited allows him to work on innovative solutions that address critical healthcare challenges. His expertise in biotechnology has positioned him as a valuable asset in the field.
Collaborations
Some of his notable coworkers include Abhishek Kulshrestha and Sudeep Sabde. Their collaboration contributes to the advancement of research and development in the biotechnology sector.
Conclusion
Ravi Shankar Maurya's contributions to the field of biotechnology, particularly through his patent on detecting insulin antibodies, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the lives of many individuals managing diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile